Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression
- PMID: 33931304
- PMCID: PMC8065236
- DOI: 10.1016/j.parkreldis.2021.04.019
Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression
Abstract
Background: Parkinson's Disease (PD) is among one of the common comorbidities in older patients. People with PD may be more vulnerable to severe pneumonia, due to the impairment of pulmonary function. Currently, the association between PD and COVID-19 is not yet established. This study aims to analyze the relationship between PD and in-hospital outcomes of COVID-19.
Materials and methods: We systematically searched the PubMed and Europe PMC database using specific keywords related to our aims until December 25th, 2020. All articles published on COVID-19 and Parkinson's Disease were retrieved. The quality of the study was assessed using the Newcastle Ottawa Scale (NOS) tool for observational studies and Joanna Briggs Institute (JBI) Critical Appraisal Tools for cross-sectional studies. Statistical analysis was done using Review Manager 5.4 software.
Results: A total of 12 studies with 103,874 COVID-19 patients were included in this meta-analysis. This meta-analysis showed that Parkinson's Disease was associated with poor in-hospital outcomes [[OR 2.64 (95% CI 1.75-3.99), p < 0.00001, I2 = 81%] and its subgroup which comprised of severe COVID-19 [OR 2.61 (95% CI 1.98-3.43), p < 0.00001, I2 = 0%] and mortality from COVID-19 [RR 2.63 (95% CI 1.50-4.60), p = 0.0007, I2 = 91%]. Meta-regression showed that the association was influenced by age (p = 0.05), but not by gender (p = 0.46) and dementia (p = 0.23).
Conclusions: Extra care and close monitoring should be provided to Parkinson's Disease patients to minimize the risk of infections, preventing the development of severe and mortality outcomes.
Keywords: COVID-19; Coronavirus disease 2019; Movement disorder; Neurologic disease; Parkinson's disease.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
None.
Figures




Similar articles
-
Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis.Arch Gerontol Geriatr. 2021 Mar-Apr;93:104299. doi: 10.1016/j.archger.2020.104299. Epub 2020 Nov 19. Arch Gerontol Geriatr. 2021. PMID: 33285424 Free PMC article.
-
Delirium is a good predictor for poor outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.J Psychiatr Res. 2021 Oct;142:361-368. doi: 10.1016/j.jpsychires.2021.08.031. Epub 2021 Aug 20. J Psychiatr Res. 2021. PMID: 34425488 Free PMC article.
-
Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis.Sleep Med. 2021 Jun;82:47-53. doi: 10.1016/j.sleep.2021.03.029. Epub 2021 Apr 1. Sleep Med. 2021. PMID: 33892451 Free PMC article.
-
Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression.Nutr Metab Cardiovasc Dis. 2021 Jun 7;31(6):1662-1670. doi: 10.1016/j.numecd.2021.02.020. Epub 2021 Feb 27. Nutr Metab Cardiovasc Dis. 2021. PMID: 33838992 Free PMC article.
-
Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression.AIDS Res Hum Retroviruses. 2021 Jan 27. doi: 10.1089/AID.2020.0307. Online ahead of print. AIDS Res Hum Retroviruses. 2021. Retraction in: AIDS Res Hum Retroviruses. 2021 Jun;37(6):503. doi: 10.1089/aid.2020.0307.retract. PMID: 33499744 Retracted.
Cited by
-
Vulnerability of Parkinson's Patients to COVID-19 and Its Consequences and Effects on Them: A Systematic Review.Parkinsons Dis. 2023 Apr 24;2023:6272982. doi: 10.1155/2023/6272982. eCollection 2023. Parkinsons Dis. 2023. PMID: 37144210 Free PMC article. Review.
-
Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis.Expert Rev Anti Infect Ther. 2022 Mar;20(3):425-434. doi: 10.1080/14787210.2021.1982695. Epub 2021 Sep 29. Expert Rev Anti Infect Ther. 2022. PMID: 34538216 Free PMC article.
-
Parkinson's disease related mortality: Long-term trends and impact of COVID-19 pandemic waves.Parkinsonism Relat Disord. 2022 May;98:75-77. doi: 10.1016/j.parkreldis.2022.04.011. Epub 2022 Apr 25. Parkinsonism Relat Disord. 2022. PMID: 35490543 Free PMC article.
-
Exacerbation of Pre-existing Neurological Symptoms With COVID-19 in Patients With Chronic Neurological Diseases: An Updated Systematic Review.Cureus. 2022 Sep 18;14(9):e29297. doi: 10.7759/cureus.29297. eCollection 2022 Sep. Cureus. 2022. PMID: 36277564 Free PMC article. Review.
-
No genetic link between Parkinson's disease and SARS-CoV-2 infection: a two-sample Mendelian randomization study.Front Neurol. 2024 Jun 28;15:1393888. doi: 10.3389/fneur.2024.1393888. eCollection 2024. Front Neurol. 2024. PMID: 39006236 Free PMC article.
References
-
- World Health Organization Coronavirus disease (COVID-19): weekly epidemiological update – 22 December 2020. 2020. https://www.who.int/publications/m/item/weekly-epidemiological-update---...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical